Login

Virginie Morgon Unveils Eurazeo's September Initiatives | Virginie Morgon, CEO, Eurazeo. 00:10:00

Share On Facebook Share On Twitter

Eurazeo's Latest Update: Virginie Morgon, September Highlight

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Institutions who provide the FUEL for our FOCUS on helping disruptive founders|Maggie Vo,Managing General Partner and Chief Investment Officer,Fuel Venture Capital
00:10:00
Constantine Metal Resources: High-Grade Polymetallic Opportunity in Alaska
00:10:00
"Empowering CEO/Advisors: The Impact of Dynasty Financial Partners' Collaboration with MIT Sloan"
00:10:00
Navigating Darkness: Writing Memoirs of Mental Illness|Meg Kissinger,Professor,Columbia University
00:10:00
JV Partners Seeked by Avrupa Minerals CEO for European Assets | Paul Kuhn, President & CEO, Avrupa Minerals Ltd. (IE)
00:10:00
Unlocking the Potential of Medicinal Cannabis: Innovations in Therapeutic Solutions | Mark Lucas, CEO, Cannasouth Ltd.
00:10:00
The Critical Need for Historical Knowledge in Military Strategy
00:10:00
New Brunswick's Third Session: Legislative Highlights | Mike Holland - Minister of Natural Resources and Energy Development
00:10:00
Denison Mines Focuses on Advanced Uranium Development in Saskatchewan's Athabasca Basin
00:10:00
Tech Innovation in Home Services: Insights from Angi CEO Oisin Hanrahan | Oisin Hanrahan, CEO, Angi Inc.
00:10:00
Interview with Anthony Purcell, Vice President of Sales for Asia at Aspen Aerogels, Inc.|Donald R. Young is President, Chief Executive Officer & Director, Aspen Aerogels, Inc.
00:10:00
Drs. Asebedo & Browning on Client Psychology and Portfolio Withdrawal Rates | Daniel Yerger - President of MY Wealth Planners

© 2026 Nehu